Home > Healthcare > Biotechnology > Bioservices > Single-use Bioreactors Market

Single-use Bioreactors Market Share

Report ID: GMI6940
Published Date: Oct 2023
Report Format: PDF

Download Free Sample

Single-use Bioreactors Market Share

The single-use bioreactors industry is consolidated in nature, with major companies competing to offer superior products in this business space. Prominent players such as GE Healthcare holds a significant share in this market. These companies are diligently directing their efforts towards continuous product innovation to gain substantial market share. For instance, GE Healthcare Life Sciences introduced Xcellerex XDR, to minimize production risks, enhance the purity, and facilitate maximum potency.

Some of the eminent market participants operating in the single-use bioreactors industry include:

Thermo Fisher Scientific
Solaris Biotech Solutions
Shanghai Bailun Biotechnology Co. Ltd.
Sartorius Stedim Biotech Group
Pierre Guerin Sas (Engie)
PBS Biotech
Danaher Corporation
Merck Group
GEA Group Aktiengesellschaft
Eppendorf AG
CESCO Bioengineering Co. Ltd.
CerCell ApS
Cellexus Ltd
Bbi Biotech
Applikon Biotechnology, Inc. (Getinge)

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Single-use bioreactors industry size was USD 2.1 billion in 2022 and is estimated to reach USD 9.2 billion by 2032 due to the surging prevalence of chronic disorders and severe infections worldwide.

Stirred tank single-use bioreactors industry size reached USD 1.5 billion in 2022 owing to their assistance to eliminate the need for cleaning and sterilization between batches.

Some of the key single-use bioreactors market players include Thermo Fisher Scientific, Solaris Biotech Solutions, Shanghai Bailun Biotechnology Co. Ltd., Sartorius Stedim Biotech Group, Pierre Guerin Sas (Engie), PBS Biotech, and Danaher Corporation.

U.S. single-use bioreactors industry size was USD 795 million in 2022 and is predicted to witness substantial growth up to 2032 due to the increasing healthcare expenditure on R& D activities.